Norway established in 2013 a framework for the introduction of innovations into the health care system through either a national or hospital-based health technology assessment. This framework is called the “New Method”.
Within this framework, all innovations should undergo HTA before being funded. If the method concerns only one or two hospitals, the assessment shall be initiated by clinicians and conducted at the hospital level. The final report is disseminated via a mini-HTA database. If the method is of national concern, it undergoes Single Technology Appraisal at the national level followed by the funding decision by the group of payers (Decision Forum, Beslutningsforum).
In March 2021, the following five mini-HTAs were initiated in Norway:
- Harpoon (Edwards Lifesciences), transapical neochordae by Oslo University Hospital
- Tricuspid clip by Oslo University Hospital
- Weight duvet used as a treatment aid at home by Oslo University Hospital
- Home monitoring of lung function - portable and hand-held spirometry with "interface" by Oslo University Hospital
- The cost-effectiveness of an insulin pump or CGM replacement by Akershus University Hospital
The finalized assessments will be published in the National Database for Mini-Method Assessments.
See the full details in Norwegian here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First, EU issues of both newsletters are available for download free-of-charge.
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).